Lexaria Bioscience (LEXX) Change in Cash (2010 - 2026)

Lexaria Bioscience has disclosed Change in Cash across 17 years of filings, most recently posting $846908.0 for Q1 2026.

• Change in Cash for Q1 2026 came in at $846908.0, up 152.63% year-over-year; the trailing twelve-month figure through Feb 2026 was -$1.3 million (down 176.03% YoY), and the FY2025 annual result was -$4.7 million, down 191.26% from the prior year.
• Change in Cash came in at $846908.0 for Q1 2026 at Lexaria Bioscience, down from $2.5 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $3.8 million in Q2 2024 to a low of -$2.8 million in Q3 2025.
• The 5-year median for Change in Cash is -$1.3 million (2023), against an average of -$267890.0.
• Across the five-year window, Change in Cash soared 3569.34% in 2024 and plunged 158.49% in 2025, its largest moves.
• Lexaria Bioscience's Change in Cash stood at -$1.3 million in 2022, then surged by 147.03% to $602063.0 in 2023, then surged by 162.16% to $1.6 million in 2024, then surged by 57.07% to $2.5 million in 2025, then slumped by 65.84% to $846908.0 in 2026.
• The last three Change in Cash figures came in at $846908.0 (Q1 2026), $2.5 million (Q4 2025), and -$2.8 million (Q3 2025), per Business Quant data.